Angiogenesis in hematologic malignancies and its clinical implications

被引:20
作者
Yang, RC
Han, ZC
机构
[1] CAMS, Inst Hematol, State Key Lab Exptl Hematol, Tianjin 300020, Peoples R China
[2] PUMC, Tianjin 300020, Peoples R China
[3] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
关键词
angiogenesis; hematopoiesis; prognosis; angiogenic factor; treatment;
D O I
10.1007/BF02982037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiogenesis is defined as a neoformation of blood vessels of capillary origin. Hematopoiesis is closely Linked with angiogenesis, for they share a common ancestor, the hemangioblast. Although it is well established that growth in solid tumors is dependent on angiogenesis, its role in hematologic malignancies has not yet been clarified. In this review, the direct evidence, ie, increased microvessel density, and the indirect evidence, ie, elevated level of angiogenic factors or overexpression of messenger RNA or protein of angiogenic factors, for and against the role of angiogenesis in the development and progression of hematologic malignancies are presented. (C)2002 The Japanese Society of Hematology.
引用
收藏
页码:246 / 256
页数:11
相关论文
共 177 条
  • [1] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [2] Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
    Aguayo, A
    Kantarjian, H
    Manshouri, T
    Gidel, C
    Estey, E
    Thomas, D
    Koller, C
    Estrov, Z
    O'Brien, S
    Keating, M
    Freireich, E
    Albitar, M
    [J]. BLOOD, 2000, 96 (06) : 2240 - 2245
  • [3] Aguayo A, 2000, BLOOD, V96, P768
  • [4] Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
    Aguayo, A
    Estey, E
    Kantarjian, H
    Mansouri, T
    Gidel, C
    Keating, M
    Giles, F
    Estrov, Z
    Barlogie, B
    Albitar, M
    [J]. BLOOD, 1999, 94 (11) : 3717 - 3721
  • [5] Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL)
    Aguayo, A
    Manshouri, T
    O'Brien, S
    Keating, M
    Beran, M
    Koller, C
    Kantarjian, H
    Rogers, A
    Albitar, M
    [J]. LEUKEMIA RESEARCH, 2001, 25 (04) : 279 - 285
  • [6] Clinical significance of microvessel density in multiple myeloma patients
    Ahn, MH
    Park, CK
    Choi, JH
    Lee, WM
    Lee, YY
    Choi, IY
    Kim, IS
    Lee, WS
    Ki, M
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (01) : 45 - 50
  • [7] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [8] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
    Asahara, T
    Masuda, H
    Takahashi, T
    Kalka, C
    Pastore, C
    Silver, M
    Kearne, M
    Magner, M
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 221 - 228
  • [9] VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
    Asahara, T
    Takahashi, T
    Masuda, H
    Kalka, C
    Chen, DH
    Iwaguro, H
    Inai, Y
    Silver, M
    Isner, JM
    [J]. EMBO JOURNAL, 1999, 18 (14) : 3964 - 3972
  • [10] Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas
    Bairey, O
    Zimra, Y
    Kaganovsky, E
    Shaklai, M
    Okon, E
    Rabizadeh, E
    [J]. MEDICAL ONCOLOGY, 2000, 17 (04) : 314 - 318